OPRX Q3 2024 Earnings — OptimizeRx Corporation Revenue & Financial Results | Market Cap Arena

OPRXOptimizeRx Corporation

$128M

Q3 2024 Earnings

Healthcare Medical - Healthcare Information Services

Income Statement

Revenue

$21M+30.5% YoY

Gross Profit

$13M63.1% margin

Operating Income

-$9M-40.2% margin

Net Income

-$9M-42.8% margin

EPS (Diluted)

$-0.50

QoQ Revenue Growth

+13.3%

Cash Flow

Operating Cash Flow

$2M

Free Cash Flow

$2M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$165M

Total Liabilities

$51M

Stockholders' Equity

$114M

Cash & Equivalents

$16M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$21M	$16M	+30.5%
Gross Profit	$13M	$10M	+37.2%
Operating Income	-$9M	-$4M	-141.0%
Net Income	-$9M	-$3M	-218.5%